Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Breast Cancer

Free Subscription Articles published in J Surg Oncol Retrieve available abstracts of 91 articles: HTML format

Single Articles

January 2026
1. HICKEY A, De la Cruz Ku G, King C, Franco C, et al
   Do Racial and Income Disparities Exist in the Application of 21-Gene Recurrence Score?
   J Surg Oncol. 2026;133:16-30.
   PubMed     Abstract available
   
   
   December 2025
2. ESGUEVA AJ, Tomatis M, Ponti A, Marotti L, et al
   Changing Practices in Axillary Surgery After Neoadjuvant Breast Cancer Therapy: Insights From the EUSOMA European Database.
   J Surg Oncol. 2025 Dec 18. doi: 10.1002/jso.70158.
   PubMed     Abstract available
   
   
   
3. DE LA CRUZ KU G, Desai A, Ho I, King C, et al
   Post-Operative Outcomes Across the Levels of Oncoplastic Breast Surgery According to the American Society of Breast Surgeons Oncoplastic Surgery Definition and Classification System.
   J Surg Oncol. 2025;132:1307-1316.
   PubMed     Abstract available
   
   
   November 2025
4. ALBUAINAIN RY, Althawadi R, Eid R, Abdulla HA, et al
   Oncological Outcomes of Omitting Axillary Surgery in Early Breast Cancer: A Systematic Review and Meta-Analysis.
   J Surg Oncol. 2025 Nov 26. doi: 10.1002/jso.70145.
   PubMed     Abstract available
   
   
   
5. AUBREY JM, Liefeld HR, Armstrong C, Levine A, et al
   Prospective Review of Practice Patterns in Breast Cancer Surgery Facilitates Rapid Practice Change, Reduced Clinical Variation, and Cost Savings.
   J Surg Oncol. 2025 Nov 16. doi: 10.1002/jso.70130.
   PubMed     Abstract available
   
   
   
6. DA SILVA LFCM, Carneiro FP, Motoyama AB
   MicroRNA Expression in Breast Cancer Patients, an Integrative Review.
   J Surg Oncol. 2025 Nov 16. doi: 10.1002/jso.70132.
   PubMed     Abstract available
   
   
   
7. WANG L, Zhou J, Zhao H
   Letter to the Editor: Comment on: "Factors Associated With Residual Positive Lymph Nodes With Targeted Axillary Lymph Node Dissection for Breast Cancer and Accuracy of Clipped Node Retrieval in Non-Mapping Patients".
   J Surg Oncol. 2025 Nov 6. doi: 10.1002/jso.70126.
   PubMed    
   
   
   
8. GOLDHABER NH, O'Keefe TJ, Longo L, Blair SL, et al
   Effect of Neoadjuvant Hormonal Therapy on Breast Conservation in Invasive Ductal Versus Lobular Carcinoma of the Breast: A Comparative Analysis.
   J Surg Oncol. 2025;132:1011-1018.
   PubMed     Abstract available
   
   
   
9. GHOSH K, Kuchta K, Alva D, Seth AK, et al
   Is Prepectoral Implant Reconstruction Associated With Better Physical Well-Being?
   J Surg Oncol. 2025;132:1071-1075.
   PubMed     Abstract available
   
   
   October 2025
10. ALTUNDAG K
    Liquid Biopsy in Metastatic Breast Cancer: Adoption Lags Despite Growing Evidence.
    J Surg Oncol. 2025 Oct 10. doi: 10.1002/jso.70107.
    PubMed    
    
    
    
11. KIM M, Gilliland JL, Jiang CZ, Parnes MF, et al
    Sexual Health in Postmastectomy Breast Reconstruction Patients and Value of an Intervention: A Qualitative Study.
    J Surg Oncol. 2025;132:825-835.
    PubMed     Abstract available
    
    
    
12. WANG X, Shao Z, Zhu H, Zhang Q, et al
    Evolving Trends in Postmastectomy Breast Reconstruction With Autologous Tissues: A Large-Scale, 24-Year Retrospective Study in China.
    J Surg Oncol. 2025;132:845-852.
    PubMed     Abstract available
    
    
    September 2025
13. REDAELLI M, Steadman JA, Hoskin TL, Hieken TJ, et al
    Does RECIST 1.1 Predict Nodal Response to Neoadjuvant Chemo-Immunotherapy in Breast Cancer?
    J Surg Oncol. 2025 Sep 24. doi: 10.1002/jso.70096.
    PubMed     Abstract available
    
    
    
14. ZHANG X, Chen Y, Wu Q, Yu Y, et al
    Safety Analysis of Omitting Radiotherapy After Breast-Conserving Surgery in Patients With Early-Stage Breast Cancer: A Meta-Analysis Based on Randomized Controlled Trials.
    J Surg Oncol. 2025 Sep 20. doi: 10.1002/jso.70091.
    PubMed     Abstract available
    
    
    
15. NGUYEN AT, Li RA, Ontiveros NC, Adam TH, et al
    Utility of the Social Vulnerability Index in Addressing Breast Cancer Disparities: A Meta-Analysis.
    J Surg Oncol. 2025 Sep 20. doi: 10.1002/jso.70080.
    PubMed     Abstract available
    
    
    
16. EPHRAIM R, Kar M, Sultania M, Naik S, et al
    Factors Influencing the Choice of Mastectomy Over Breast Conservation Surgery in Early Breast Cancer: A Prospective Qualitative Exploration of Patient Perspectives From India.
    J Surg Oncol. 2025 Sep 14. doi: 10.1002/jso.70088.
    PubMed     Abstract available
    
    
    August 2025
17. BRABENDER DE, Griffiths A, Lu KA, Armstrong K, et al
    Factors Associated With Residual Positive Lymph Nodes With Targeted Axillary Lymph Node Dissection for Breast Cancer and Accuracy of Clipped Node Retrieval in Non-Mapping Patients.
    J Surg Oncol. 2025 Aug 21. doi: 10.1002/jso.70070.
    PubMed     Abstract available
    
    
    
18. LIU P, Liu Y, Xie Y, Hu S, et al
    Potential of Combination of CE-MRI and Serum Her-2neu Extracellular Domain in Evaluating Effectiveness of Neoadjuvant Chemotherapy in Breast Cancer.
    J Surg Oncol. 2025 Aug 11. doi: 10.1002/jso.70058.
    PubMed     Abstract available
    
    
    
19. KIM M, Bubberman J, Amakiri U, Kim YS, et al
    Culture Impacts Sexual Well-Being in Autologous Breast Reconstruction: A Multi-Continental Examination.
    J Surg Oncol. 2025;132:375-383.
    PubMed     Abstract available
    
    
    
20. GABAY AJ, Chen J, Stern CS, Gibbons C, et al
    Predicting Breast Reconstruction Readmission, Reoperation, and Prolonged Length of Stay: A Machine Learning Approach.
    J Surg Oncol. 2025;132:345-353.
    PubMed     Abstract available
    
    
    
21. LEVY J, Amakiri U, Shammas RL, Graziano FD, et al
    Longitudinal Modeling in Surgical Oncology Research: A Primer Examining Patient-Reported Outcomes.
    J Surg Oncol. 2025;132:294-307.
    PubMed     Abstract available
    
    
    July 2025
22. SUPPAN I, Lundon D, Garg PK, Caballero C, et al
    Clinical Use of Liquid Biopsy in Metastatic Breast Cancer-An ESSO-EYSAC International Survey.
    J Surg Oncol. 2025 Jul 14. doi: 10.1002/jso.70045.
    PubMed     Abstract available
    
    
    
23. WILLERT CB, Bidstrup P, Mellemkjaer L, Kalstrup J, et al
    Bilateral Risk-Reducing Mastectomy With Immediate Breast Reconstruction Lowers Concerns of Breast Cancer in Women With a High-Risk Genetic Predisposition for Breast Cancer Compared With a Radiological Imaging Surveillance Group.
    J Surg Oncol. 2025 Jul 9. doi: 10.1002/jso.70029.
    PubMed     Abstract available
    
    
    
24. WAREHAM C, Bertaux B, Chahine E, Homsy C, et al
    Geographical Presence of Plastic Surgeons in Relation to Breast Surgeons in the United States for Breast Reconstruction.
    J Surg Oncol. 2025;132:22-27.
    PubMed     Abstract available
    
    
    June 2025
25. FANNING JE, Chen A, Thomson S, Tillotson E, et al
    Epitrochlear and Humeral Lymph Nodes: A Biomarker for Deep Lymphatic Function and Implications for Breast Cancer-Related Lymphedema Risk.
    J Surg Oncol. 2025 Jun 24. doi: 10.1002/jso.70002.
    PubMed     Abstract available
    
    
    
26. VARAGUR K, Ribaudo JG, Keller M, Fadell NR, et al
    Understanding Trends in Incidence and Management of Pregnancy-Associated Breast Cancer in a National Sample Using Claims Data.
    J Surg Oncol. 2025 Jun 19. doi: 10.1002/jso.70010.
    PubMed     Abstract available
    
    
    
27. VASCONCELOS CS, Salgado MRT, Martins MR, Anunciacao CEC, et al
    Soluble sFas, sFasL, sPD1, and sPDL1 Analyses in the Peripheral Blood of Locally Advanced Breast Cancer Patients Before and After Neoadjuvant Chemotherapy.
    J Surg Oncol. 2025 Jun 2. doi: 10.1002/jso.27723.
    PubMed     Abstract available
    
    
    
28. COLEMAN-BELIN JC, Kim M, Graziano FD, Boe LA, et al
    Combined Autologous Breast Reconstruction and Gynecologic Procedures: Does Timing Affect Clinical and Patient-Reported Outcomes?
    J Surg Oncol. 2025;131:1400-1406.
    PubMed     Abstract available
    
    
    
29. STERN CS, Shammas RL, Montes ES, Boe LA, et al
    Improving the Evaluation of Aesthetic Outcomes in DIEP Flap Breast Reconstruction: Validation of the Aesthetic Grading Tool.
    J Surg Oncol. 2025;131:1407-1412.
    PubMed     Abstract available
    
    
    
30. HUANG A, Koesters E, Garza RM, Hanson SE, et al
    A Single Institution Experience With Immediate Lymphatic Reconstruction: Impact of Insurance Coverage on Risk Reduction.
    J Surg Oncol. 2025;131:1393-1399.
    PubMed     Abstract available
    
    
    
31. NGUYEN A, Chon J, Coles B, Galiano R, et al
    Disparities in Breast Reconstruction After Mastectomy in Southeast Asia: A Systematic Review.
    J Surg Oncol. 2025;131:1601-1619.
    PubMed     Abstract available
    
    
    May 2025
32. VAN DECAR SG, Barbera EL, Adams AM, Shore JM, et al
    A Validated Ultrasound-Based Scoring System to Stratify Risk of Axillary Metastasis in Breast Cancer: AX-RADS (Axillary Imaging Reporting and Data System).
    J Surg Oncol. 2025 May 20. doi: 10.1002/jso.28159.
    PubMed     Abstract available
    
    
    
33. DALY GE, Collins KL, Malone SE, Garreau J, et al
    Incidence of Deleterious Genetic Mutations in Newly Diagnosed Breast Cancer Patients Over the Age of 65: Is It Time to Expand Testing Parameters?
    J Surg Oncol. 2025 May 13. doi: 10.1002/jso.28151.
    PubMed     Abstract available
    
    
    
34. CANO-LALLAVE E, Frutos-Bernal E, Anciones-Polo M, Serrano-Sanchez E, et al
    Optimizing Lymphedema Management After Breast Cancer: Predictive Risk Models in Clinical Practice.
    J Surg Oncol. 2025 May 13. doi: 10.1002/jso.28146.
    PubMed     Abstract available
    
    
    
35. GRAZIANO FD, White DR, Plotsker EL, Shammas RL, et al
    Enhancing Patient Decision-Making in Breast Reconstruction: A Systematic Review of Decision Aid Efficacy.
    J Surg Oncol. 2025;131:1222-1235.
    PubMed     Abstract available
    
    
    
36. ZINDANI S, Khalil M, Rashid Z, Altaf A, et al
    Association of Socio-Environmental Burden and Inequality With Cancer Screening and Mortality.
    J Surg Oncol. 2025;131:1110-1117.
    PubMed     Abstract available
    
    
    
37. KIEFER J, Paidisetty P, Elmorsi RAI, Nguyen CHM, et al
    Contemporary Trends in Reconstruction for Patients With Sarcoma of the Breast.
    J Surg Oncol. 2025;131:1013-1023.
    PubMed     Abstract available
    
    
    
38. GRAZIANO FD, Amakiri UO, Levy J, Shammas RL, et al
    Perioperative Venous Thromboembolism Chemoprophylaxis Does Not Increase Risk of Complications in Free Flap Breast Reconstruction.
    J Surg Oncol. 2025;131:1211-1221.
    PubMed     Abstract available
    
    
    April 2025
39. DAVE N, Hajj JP, Ahmed S, Hulsman L, et al
    Immediate Breast Reconstruction for Inflammatory Breast Carcinoma: A Scoping Review.
    J Surg Oncol. 2025;131:775-781.
    PubMed     Abstract available
    
    
    March 2025
40. CHIU CW, Su CM, Liao LM, Su CS, et al
    Upstaging Prediction Model to Guide the Application of Sentinel Lymph Node Biopsy in Patients With Ductal Carcinoma In Situ: A Retrospective Comparative Study.
    J Surg Oncol. 2025;131:571-579.
    PubMed     Abstract available
    
    
    February 2025
41. CLARK P, DiPasquale A, Cocco D, Brown A, et al
    Oncoplastic Surgery: Where Are We Now?
    J Surg Oncol. 2025;131:124-132.
    PubMed     Abstract available
    
    
    
42. MCADAMS CD, Clevenger N, Nicholson K, Pesce C, et al
    Proportion of Patients With Ductal Carcinoma In Situ That Qualify for Observation Criteria Set Forth by Clinical Trials.
    J Surg Oncol. 2025;131:115-123.
    PubMed     Abstract available
    
    
    
43. LEFF DR
    Technologies and techniques to improve precision in breast conserving surgery.
    J Surg Oncol. 2025;131:108-114.
    PubMed     Abstract available
    
    
    January 2025
44. DE LA CRUZ KU G, Desai A, Hickey A, Valcarcel B, et al
    Disparities in Triple Negative Breast Cancer Among Hispanic Population Living in Latin America Versus the United States.
    J Surg Oncol. 2025 Jan 13. doi: 10.1002/jso.28088.
    PubMed     Abstract available
    
    
    December 2024
45. ARREY EN, GoPaul D, Anderson D, Okoli J, et al
    Addressing Breast Cancer Disparities: A Comprehensive Approach to Health Equity.
    J Surg Oncol. 2024 Dec 19. doi: 10.1002/jso.28011.
    PubMed     Abstract available
    
    
    
46. WANG X, Jin J, Zhu Y, Liu X, et al
    Letter to "Body Mass Index and Breast Cancer-Related Lymphedema: A Retrospective Cohort Study".
    J Surg Oncol. 2024 Dec 19. doi: 10.1002/jso.28055.
    PubMed    
    
    
    
47. LI F, Wei Y, Li L, Chen F, et al
    Collagen Density Is Associated With Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients.
    J Surg Oncol. 2024 Dec 19. doi: 10.1002/jso.28046.
    PubMed     Abstract available
    
    
    
48. NAJAFALI D, Siotos C, Kokosis G
    Taxanes and Breast Cancer-Related Lymphedema.
    J Surg Oncol. 2024 Dec 15. doi: 10.1002/jso.28017.
    PubMed    
    
    
    November 2024
49. NGUYEN A, Duckworth E, Pascua D, Coles B, et al
    Disparities in Breast Cancer Treatment and Reconstruction Among Native Hawaiian and Pacific Islander Women: Systematic Review and Meta-Analysis.
    J Surg Oncol. 2024 Nov 25. doi: 10.1002/jso.27994.
    PubMed     Abstract available
    
    
    
50. HANNOUN-LEVI JM, Polgar C, Strnad V, Gutierrez C, et al
    With Regard to Schwieger L. et al. Intraoperative Radiation Therapy for Early-Stage Breast Cancer. DOI: 101002/jso27814.
    J Surg Oncol. 2024 Nov 11. doi: 10.1002/jso.27971.
    PubMed    
    
    
    October 2024
51. MCSHANE N, Zaborowski A, O'Reilly M, McCartan D, et al
    Hormone Receptor Positive Breast Cancer in Young Women: A Review.
    J Surg Oncol. 2024 Oct 29. doi: 10.1002/jso.27963.
    PubMed     Abstract available
    
    
    
52. JIANG Q, Hu H, Liao J, Duan P, et al
    Body Mass Index and Breast Cancer-Related Lymphedema: A Retrospective Cohort Study.
    J Surg Oncol. 2024 Oct 28. doi: 10.1002/jso.27969.
    PubMed     Abstract available
    
    
    
53. HANSSEN D, Champion N, Ngo J, Palfi S, et al
    Frailty and Malnutrition in Surgical Outcomes of Elderly Breast Cancer Patients.
    J Surg Oncol. 2024 Oct 10. doi: 10.1002/jso.27940.
    PubMed     Abstract available
    
    
    
54. LIU C, Zhao H, Zhou Y
    Comment On: "Factors Influencing Prophylactic Surgical Intervention in Women With Genetic Predisposition for Breast Cancer".
    J Surg Oncol. 2024 Oct 8. doi: 10.1002/jso.27930.
    PubMed    
    
    
    September 2024
55. ALTUNDAG K
    The Association of Taxanes With Breast Cancer-Related Lymphedema.
    J Surg Oncol. 2024 Sep 19. doi: 10.1002/jso.27906.
    PubMed    
    
    
    
56. KU GC, Wareham C, King C, Koul A, et al
    Is Oncoplastic Surgery Safe in High-Risk Breast Cancer Phenotypes?
    J Surg Oncol. 2024 Sep 16. doi: 10.1002/jso.27899.
    PubMed     Abstract available
    
    
    
57. ZHAO H, Xu J, Zhou Y
    Comment On: "Assessing Breast Cancer-Related Lymphedema Screening and Treatment Gaps in a Safety-Net Hospital".
    J Surg Oncol. 2024 Sep 9. doi: 10.1002/jso.27894.
    PubMed    
    
    
    
58. HUMAR P, Balogun Z, Douglas N, Glenney A, et al
    Factors influencing prophylactic surgical intervention in women with genetic predisposition for breast cancer.
    J Surg Oncol. 2024 Sep 1. doi: 10.1002/jso.27817.
    PubMed     Abstract available
    
    
    
59. SELBY LV, Clark E, Chen JL, Tinoco G, et al
    Use of neoadjuvant paclitaxel in breast angiosarcoma-Impact on surgical resection and response rates.
    J Surg Oncol. 2024;130:579-585.
    PubMed     Abstract available
    
    
    August 2024
60. SCHWIEGER L, Switchenko JM, Cao Y, Amaniera I, et al
    Intraoperative radiation therapy for early-stage breast cancer.
    J Surg Oncol. 2024 Aug 29. doi: 10.1002/jso.27814.
    PubMed     Abstract available
    
    
    
61. SIOTOS C, Arnold SH, Seu M, Lunt L, et al
    Breast cancer-related lymphedema: A comprehensive analysis of risk factors.
    J Surg Oncol. 2024 Aug 27. doi: 10.1002/jso.27841.
    PubMed     Abstract available
    
    
    
62. ALTUNDAG K
    Women with breast cancer who have second primary malignancies: Further information is still needed.
    J Surg Oncol. 2024 Aug 9. doi: 10.1002/jso.27809.
    PubMed    
    
    
    
63. STEADMAN JA, Hieken TJ
    Advances from targeted therapy for non-metastatic HER2-positive inflammatory breast cancer.
    J Surg Oncol. 2024 Aug 5. doi: 10.1002/jso.27797.
    PubMed     Abstract available
    
    
    
64. LOU Y, Qu M
    Letter to the Editor: Comment on: "Reliability of artificial intelligence chatbot responses to frequently asked questions in breast surgical oncology".
    J Surg Oncol. 2024;130:347-348.
    PubMed    
    
    
    
65. YANG AZ, Hyland CJ, Miller AS, Killelea BK, et al
    Local practice variations and payer differences underlie state-wide disparities in oncoplastic breast surgery.
    J Surg Oncol. 2024;130:210-221.
    PubMed     Abstract available
    
    
    
66. DAUNGSUPAWONGM H, Wiwanitkit V
    Reliability of artificial intelligence chatbot responses to frequently asked questions in breast surgical oncology: Correspondence.
    J Surg Oncol. 2024;130:338.
    PubMed    
    
    
    
67. ROLDAN-VASQUEZ E, Mitri S, Bhasin S, Bharani T, et al
    Reliability of artificial intelligence chatbot responses to frequently asked questions in breast surgical oncology.
    J Surg Oncol. 2024;130:188-203.
    PubMed     Abstract available
    
    
    July 2024
68. CHEN C, Tseng J, Amersi F, Silberman AW, et al
    Second primary malignancies in women with breast cancer.
    J Surg Oncol. 2024 Jul 19. doi: 10.1002/jso.27785.
    PubMed     Abstract available
    
    
    
69. GARAYUA-CRUZ L, Broida SE, Okuno SH, Robinson SI, et al
    Outcomes of non-angiosarcoma radiation-associated soft tissue sarcomas of the chest.
    J Surg Oncol. 2024;130:56-63.
    PubMed     Abstract available
    
    
    
70. UPADHYAY N, Wolska J
    Imaging the dense breast.
    J Surg Oncol. 2024;130:29-35.
    PubMed     Abstract available
    
    
    
71. BOLAND MR
    Modern management of the axilla.
    J Surg Oncol. 2024;130:23-28.
    PubMed     Abstract available
    
    
    June 2024
72. HYAMS DM, Bareket-Samish A, Rocha JEB, Diaz-Botero S, et al
    Selecting postoperative adjuvant systemic therapy for early-stage breast cancer: An updated assessment and systematic review of leading commercially available gene expression assays.
    J Surg Oncol. 2024 Jun 24. doi: 10.1002/jso.27692.
    PubMed     Abstract available
    
    
    
73. KELLEY K, Sener SF
    Who still needs surgical staging of the axilla for invasive breast cancer?
    J Surg Oncol. 2024 Jun 21. doi: 10.1002/jso.27753.
    PubMed     Abstract available
    
    
    
74. YOUNG S, Geary A, Zhao X, Kenzik K, et al
    Assessing breast cancer-related lymphedema screening and treatment gaps in a safety-net hospital.
    J Surg Oncol. 2024 Jun 14. doi: 10.1002/jso.27735.
    PubMed     Abstract available
    
    
    
75. SALGADO MRT, Sobral DV, Martins MR, Salgado EFMT, et al
    Expression of CD28, FAS, PD1, and CTLA4 molecules in the blood of women with triple-negative breast cancer.
    J Surg Oncol. 2024 Jun 6. doi: 10.1002/jso.27725.
    PubMed     Abstract available
    
    
    
76. SOBRAL DV, Salgado MRT, Martins MR, Vasconcelos CS, et al
    Prognostic role of SOX2 and STAT3 expression on circulating T lymphocytes and CD44+/CD24(neg) cells in the locally advanced and metastatic breast cancer.
    J Surg Oncol. 2024 Jun 2. doi: 10.1002/jso.27716.
    PubMed     Abstract available
    
    
    
77. CHEN JC, Handley D, Elsaid MI, Fisher JL, et al
    Racial disparities in disease-specific mortality and surgical management of patients with ductal carcinoma in situ with microinvasion.
    J Surg Oncol. 2024;129:1179-1186.
    PubMed     Abstract available
    
    
    
78. AMBIKA M, Lara S, Faulkner HR, Toncred S, et al
    Oncoplastic reconstruction with breast-conserving treatment versus breast-conserving treatment alone in the elderly.
    J Surg Oncol. 2024;129:1187-1191.
    PubMed     Abstract available
    
    
    
79. KIM M, Vingan P, Boe LA, Tadros AB, et al
    Nonresponse data in sexual well-being among breast reconstruction patients-who are we overlooking?
    J Surg Oncol. 2024;129:1192-1201.
    PubMed     Abstract available
    
    
    
80. REYES-MONASTERIO A, Moller MG, Lozada-Martinez ID, Narvaez-Rojas AR, et al
    Bridging frontiers: The role of a Global Breast Research Working Group.
    J Surg Oncol. 2024;129:1507-1514.
    PubMed     Abstract available
    
    
    
81. KIM M, Ali B, Graziano FD, Colvin K, et al
    Analyzing mastectomy and reconstruction weight in immediate autologous breast reconstruction: A preliminary study.
    J Surg Oncol. 2024;129:1466-1474.
    PubMed     Abstract available
    
    
    May 2024
82. DI PACE B, Padley RH
    Enhancing treatment compliance in breast cancer patients: A multi-faceted approach.
    J Surg Oncol. 2024 May 27. doi: 10.1002/jso.27679.
    PubMed    
    
    
    
83. DI PACE B, Padley RH
    Breast cancer survivorship: A viewpoint.
    J Surg Oncol. 2024 May 19. doi: 10.1002/jso.27680.
    PubMed    
    
    
    
84. KEATING N, Cevik J, Hopkins D, Lippey J, et al
    Malignant upgrade rate and associated clinicopathologic predictors for concordant intraductal papilloma without atypia: A systematic review and meta-analysis.
    J Surg Oncol. 2024;129:1025-1033.
    PubMed     Abstract available
    
    
    
85. SPIEKERMAN VAN WEEZELENBURG MA, Daemen JHT, van Kuijk SMJ, van Haaren ERM, et al
    Seroma formation after mastectomy: A systematic review and network meta-analysis of different flap fixation techniques.
    J Surg Oncol. 2024;129:1015-1024.
    PubMed     Abstract available
    
    
    
86. DI PACE B, Padley RH
    Survivorship and breast cancer: Navigating the continuum of care.
    J Surg Oncol. 2024 May 1. doi: 10.1002/jso.27671.
    PubMed    
    
    
    April 2024
87. ABAHSSAIN H, Souadka A
    Navigating the complexity of post-NAT therapy in breast cancer: The role of ctDNA testing.
    J Surg Oncol. 2024 Apr 23. doi: 10.1002/jso.27658.
    PubMed    
    
    
    
88. NTOWE KW, Lee MS, Plichta JK
    Clinical genetics in breast cancer.
    J Surg Oncol. 2024 Apr 1. doi: 10.1002/jso.27630.
    PubMed     Abstract available
    
    
    
89. SPIEKERMAN VAN WEEZELENBURG MA, de Rooij L, Aldenhoven L, van Kuijk SMJ, et al
    Drain-free mastectomy and flap fixation: The interim analysis of a randomized controlled noninferiority trial.
    J Surg Oncol. 2024;129:975-980.
    PubMed     Abstract available
    
    
    March 2024
90. VALENTE S, Roesch E
    Breast cancer survivorship.
    J Surg Oncol. 2024 Mar 27. doi: 10.1002/jso.27627.
    PubMed     Abstract available
    
    
    December 2023
91. ROCHLIN DH, Matros E, Shamsunder MG, Rubenstein R, et al
    Plastic surgery market share of breast reconstructive procedures: An analysis of two nationwide databases.
    J Surg Oncol. 2023;128:1064-1071.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.